STRUCTURE THERAPEUTICS
Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases... with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.
STRUCTURE THERAPEUTICS
Industry:
Biotechnology Health Care Medical Pharmaceutical Product Research
Founded:
2016-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.structuretx.com
Total Employee:
101+
Status:
Active
Total Funding:
1.05 B USD
Technology used in webpage:
Euro CrUX Top 50m CrUX Dataset Pound Sterling CrUX Top 5m MediaElement.js
Similar Organizations
BetaGlue Technologies
BetaGlue Technologies engages in research and offers anti-cancer products.
Blueprint Medicines
Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Bristol Myers Squibb
Bristol Myers Squibb engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals.
Codetta Biosciences
Codetta Biosciences is a company developing quantitative & digital spatial platform for nucleic acid & protein assays.
Rapt Therapeutics
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Ionis Pharmaceuticals
Ionis Pharmaceuticals is a drugmaker company.
Joyo Pharma
Joyo Pharma focuses on the research and development of drugs for the treatment of tumors, autoimmunity, metabolism, and infectious diseases.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Productboard
Productboard is a product management system that helps organizations get the right products to market faster.
Current Advisors List
Board_member
2021-10-01
Board_member
2021-10-01
Board_member
2022-03-01
Board_member
2022-01-01
Current Employees Featured
Raymond Stevens Chief Executive Officer & Founder @ Structure Therapeutics
Chief Executive Officer & Founder
2019-05-01
Jun Yoon Chief Financial Officer @ Structure Therapeutics
Chief Financial Officer
2017-01-01
Mark Bach Chief Medical Officer @ Structure Therapeutics
Chief Medical Officer
2021-06-01
Xichen Lin Chief Scientific Officer General Manager, Shanghai ShouTi @ Structure Therapeutics
Chief Scientific Officer General Manager, Shanghai ShouTi
2019-01-01
Yingli Ma Chief Technology Officer @ Structure Therapeutics
Chief Technology Officer
2021-01-01
Founder
Stock Details
Investors List
Sage Partners
Sage Partners investment in Series B - Structure Therapeutics
Surveyor Capital
Surveyor Capital investment in Series B - Structure Therapeutics
Woodline Partners
Woodline Partners investment in Series B - Structure Therapeutics
TF Capital
TF Capital investment in Series B - Structure Therapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series B - Structure Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Structure Therapeutics
Eight Roads Ventures
Eight Roads Ventures investment in Series B - Structure Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Structure Therapeutics
TCG Crossover
TCG Crossover investment in Series B - Structure Therapeutics
Biotechnology Value Fund
Biotechnology Value Fund investment in Series B - Structure Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-21 | ShouTi Appoints Ding Ding, Ph.D., as Chief Financial Officer |
Official Site Inspections
http://www.structuretx.com Semrush global rank: 1.33 M Semrush visits lastest month: 20 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Structure Therapeutics"
Home | Structure Therapeutics
Feb 27, 2025 Structure is a clinical-stage biopharmaceutical company leveraging structure-based drug design to develop more accessible oral small molecule therapeutics for the …See details»
Structure Therapeutics - LinkedIn
Structure Therapeutics is a science-driven clinical-stage biopharmaceutical company focused on discovering and developing innovative oral small molecule treatments for chronic metabolic and ...See details»
Structure Therapeutics Management Team | Org Chart
Structure Therapeutics employs 144 employees. The Structure Therapeutics management team includes Michael Liu (Director, Clinical Pharmacology and Pharmacometrics), and Pauline …See details»
Form 10-K for Structure Therapeutics INC filed 03/08/2024
Structure Therapeutics Inc. (Exact name of registrant as specified in its charter) Cayman Islands (State of Other Jurisdiction of incorporation or Organization) 601 Gateway Blvd., Suite 900 …See details»
Structure Therapeutics - PitchBook
Information on stock, financials, earnings, subsidiaries, investors, and executives for Structure Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
SEC Filings | Structure Therapeutics
The Investor Relations website contains information about Structure Therapeutics 's business for stockholders, potential investors, and financial analysts.See details»
Structure Therapeutics Inc - WhaleWisdom.com
View 13F filing holders of Structure Therapeutics Inc. 13F filings are submitted quarterly to the SEC by hedge funds and other investment managersSee details»
Structure Therapeutics Appoints Ted W. Love, M.D., to Board of …
Aug 3, 2023 Dr. Love brings more than 30 years of experience in the biopharmaceuticals industry, and currently chairs the Biotechnology Innovation Organization (BIO) Board.See details»
Jun Yoon | Structure Therapeutics
Mr. Yoon has over 20 years of industry operating experience in building and leading venture-backed biotechnology companies. He most recently served as Vice President of Corporate …See details»
Structure Therapeutics, Inc. (Structure Therapeutics, Inc.) - 药物管 …
For additional information, please visit www.structuretx.com. The content above comes from the network. if any infringement, please contact us to modify.See details»
Yingli Ma, Ph.D. | Structure Therapeutics
Dr. Ma has more than 15 years of research, technology and drug discovery experience in pharma and biotech settings. Prior to joining Structure, Dr. Ma was site head and General Manager of …See details»
Press Release - Structure Therapeutics
For additional information, please visit www.structuretx.com. Forward Looking Statements This press release contains “forward-looking statements” within the meaning of the “safe harbor” …See details»
Xichen Lin, Ph.D. | Structure Therapeutics
Dr. Lin brings close to 20 years of experience in drug discovery and development and has delivered multiple clinical candidates, including several Phase 2 assets. Prior to Structure, Dr. …See details»
Structure Therapeutics Announces Proposed Public Offering of …
SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral …See details»
Structure Therapeutics to Participate in Multiple Upcoming
Jan 30, 2025 Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences January 30, 2025 08:30 ET | Source: Structure Therapeutics Inc.See details»
7 Organizational Structure Types (With Examples) - Forbes
May 29, 2024 Every company needs an organizational structure—whether they realize it or not. The organizational structure is how the company delegates roles, responsibilities, job …See details»
Bob Gatmaitan | Structure Therapeutics
Bob is a seasoned executive with over 25 years of Human Resources leadership experience across large multinational pharmaceutical organizations and dynamic start-up biotechnology …See details»
Structure Therapeutics Announces Proposed Public Offering of …
SAN FRANCISCO, June 03, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral …See details»
Structure Therapeutics Announces Closing of Upsized Initial Public ...
SAN FRANCISCO and SHANGHAI, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company …See details»
Lisa Dixon: The head of the team supporting the “nervous system” …
1 day ago When the National Spherical Torus Experiment-Upgrade (NSTX-U) project team performed tests on its magnets and electrical systems in February 2025 to prepare for …See details»